Combined cataract–glaucoma surgery using the intracanalicular Eyepass glaucoma implant
| Autor: | Jens Jordan, Günter Karl Krieglstein, Thomas Stefan Dietlein, Anselm Jünemann, Andrea Schild, Walter Konen, Christoph Lüke |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Male
Intraocular pressure medicine.medical_specialty genetic structures medicine.medical_treatment Perforation (oil well) Microscopy Acoustic Visual Acuity Glaucoma Pilot Projects Intraocular lens Cataract Lens Implantation Intraocular Anterior Eye Segment Ophthalmology medicine Glaucoma surgery Humans Prospective Studies Glaucoma Drainage Implants Intraocular Pressure Aged Phacoemulsification business.industry Middle Aged Cataract surgery medicine.disease Trabeculotomy eye diseases Sensory Systems Surgery Treatment Outcome Feasibility Studies Female sense organs business Glaucoma Open-Angle Follow-Up Studies |
| Zdroj: | Journal of Cataract and Refractive Surgery. 34:247-252 |
| ISSN: | 0886-3350 |
| DOI: | 10.1016/j.jcrs.2007.09.029 |
| Popis: | Purpose To study prospectively the safety and pressure-reducing efficacy of the Y-shaped Eyepass glaucoma implant (GMP Vision Solutions, Inc.). Setting Departments of Ophthalmology, University of Cologne, Cologne, and University of Erlangen, Erlangen, Germany. Methods This study comprised 12 patients with primary open-angle or exfoliative glaucoma and cataract who had phacoemulsification with endocapsular implantation of a foldable intraocular lens and intracanalicular implantation of an Eyepass glaucoma implant. The implant is a silicone microtube shunt that bypasses the trabecular meshwork and connects the lumina of Schlemm canal with the anterior chamber in combined cataract–glaucoma surgery. Perioperative complications, intraocular pressure (IOP), and pressure-reducing topical medications were monitored over a preliminary follow-up. Results Perforation of the trabecular meshwork during Eyepass implantation occurred in 2 eyes; the antiglaucoma procedure was converted to trabeculotomy after the shunt was explanted, and both eyes were excluded from further follow-up. In the remaining 10 eyes, the mean maximum IOP was 30.4 mm Hg ± 7.5 (SD) (range 21 to 46 mm Hg) preoperatively, 12.0 ± 6.1 mm Hg (range 2 to 20 mm Hg) 1 day postoperatively, 17.2 ± 4.1 mm Hg (range 12 to 27 mm Hg) at 4 weeks, and 18.3 ± 4.5 mm Hg (range 12 to 25 mm Hg) at the end of the preliminary follow-up. The mean number of topical medications was 3.2 ± 0.8 preoperatively and 0.9 ± 0.7 at the end of follow-up (mean 7.1 months). Although there were no major complications requiring surgical revision, 4 eyes had an IOP of 18 or higher at the end of follow-up. Conclusion Combined cataract surgery with Eyepass shunt implantation was safe and appeared to be beneficial in glaucomatous eyes with cataract not requiring a low target IOP. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|